Press Releases

Important news and updates from Aleafia Health

Aleafia Health Named Top Performing Company of the Year for TSX Venture 50

Aleafia Health Named Top Performing Company of the Year for TSX Venture 50

Aleafia Health Ranks First Based on Key Market Performance Measures Among all TSXV Listed Companies First Time a Cannabis Company has Achieved Top Performing Company Honours TORONTO, February 21, 2019 – Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has been named the TMX Group’s 2019 TSX Venture 50 top […]

Read More
Aleafia Health Announces new President of Clinic Operations

Aleafia Health Announces new President of Clinic Operations

White to Lead Integration of Canabo Medical Clinics and GrowWise Health Post-closing of Emblem Acquisition Previously the COO of Canada’s Largest Multidisciplinary Clinic Network TORONTO, February 15, 2019 – Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has named private healthcare executive Keith White as the Company’s new President […]

Read More
Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow

Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow

Research Revenue Totalled $0.6 Million in Q3 2018 Product Data Science Fellow to Lead Evidence-Based Product Research via Proprietary, 10M Point Patient Dataset TORONTO, February 4, 2019 – Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has appointed Dr. Graham Merry, as the Company’s first Product Data Science Fellow. […]

Read More
Aleafia Health Study Indicates 45% of Patients End Benzodiazepine Use Following Medical Cannabis Treatment

Aleafia Health Study Indicates 45% of Patients End Benzodiazepine Use Following Medical Cannabis Treatment

First of its Kind Study Published in Peer-Reviewed Journal, “Cannabis and Cannabinoid Research” Authors Leveraged Aleafia’s 10 Million Point Medical Cannabis Dataset

Read More
Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited

Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited

Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator CannaPacific among Australia’s only Federally Licensed Cultivators with projected 108,000 sq. ft. Greenhouse

Read More
Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust

Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust

Aleafia Cannabis Complements CannTrust’s Supply for growing Adult-use, Medical Sales

Read More
Aleafia Completes Phase One Construction and Retrofitting of Niagara Greenhouse Facility

Aleafia Completes Phase One Construction and Retrofitting of Niagara Greenhouse Facility

Multiple Sales Streams including 15,000 kg Supply Agreement and 50,000 Patient Base

Read More
Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader

Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader

View the Aleafia & Emblem Presentation HERE Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres; Aleafia patients to access Emblem’s differentiated, high margin derivative products including capsules, oils and oral sprays, along with award-winning customer service and eCommerce platform; Regulatory acceleration with Aleafia leveraging Emblem’s […]

Read More
Aleafia Announces Results of Special Shareholders Meeting

Aleafia Announces Results of Special Shareholders Meeting

Company to Immediately Pursue NASDAQ Application Final Stages 

Read More
Letter from Chairman Julian Fantino

Letter from Chairman Julian Fantino

Over the last month, Aleafia has made significant strides towards achieving our objective of providing the best possible care for our patients, and in turn, providing real value for our shareholders. 

Read More
Aleafia Posts Record Revenue in Q3 2018, 36% Increase Over Previous Quarter

Aleafia Posts Record Revenue in Q3 2018, 36% Increase Over Previous Quarter

First Quarter of Profitability for Clinic and Cannabis Product Divisions 99% of 98,000 kg Annual Cannabis Production Capacity to Come Online in 2019

Read More
Aleafia Closes Transactions with Serruya Private Equity

Aleafia Closes Transactions with Serruya Private Equity

Transactions Positions Aleafia as Major Supplier, Retailer of Adult-use Cannabis

Read More
Aleafia to Release Q3 Results on November 26

Aleafia to Release Q3 Results on November 26

TORONTO, November 23, 2018 /Globe Newswire/ – Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), a highly differentiated cannabis company with major cannabis cultivation and medical clinic operations, will release its financial results and hold its Third Quarter Results Call on November 26, 2018. 

Read More
Aleafia and Serruya Private Equity Reach Agreement for National Retail Dispensary, top Performing Brands and $10M Investment

Aleafia and Serruya Private Equity Reach Agreement for National Retail Dispensary, top Performing Brands and $10M Investment

Transactions Positions Aleafia as Major Supplier, Retailer of Adult-use Cannabis

Read More
Aleafia Health to Launch Global Cannabis Education Platform with D2L

Aleafia Health to Launch Global Cannabis Education Platform with D2L

Platform to Provide Cannabis Education Courses

Read More